Cordasco Financial Network Lumos Pharma, Inc. Transaction History

Cordasco Financial Network

  • $138 Million
  • Q2 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 13, 2020
SELL
$13.25 - $16.5 $1,603 - $1,996
-121 Closed
0 $0
Q1 2020

Apr 24, 2020
BUY
$0.89 - $8.85 $107 - $1,070
121 New
121 $1,000

Others Institutions Holding LUMO

# of Institutions
33
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email